Cargando…
High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
Autores principales: | Pichler, Renate, Loidl, Wolfgang, Pichler, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323287/ https://www.ncbi.nlm.nih.gov/pubmed/30687612 http://dx.doi.org/10.21037/tau.2018.08.15 |
Ejemplares similares
-
Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020) -
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
por: Tulchiner, Gennadi, et al.
Publicado: (2021) -
Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial
por: Heidegger, Isabel, et al.
Publicado: (2018) -
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
por: Pichler, Renate, et al.
Publicado: (2019) -
Kindness Should Still Underline Science During the Pandemic
por: Fontúrbel, Francisco E., et al.
Publicado: (2020)